Come up with a name for your new list and we'll add to it:
Ataxion was acquired by
Luc Therapeutics on March 07, 2017.
Ataxion is a discovery-stage biopharmaceutical company developing novel therapies for rare, debilitating, and underserved neurologic diseases in partnership with Biogen. Ataxion is leveraging the expe…